TrialOrphanet journal of rare diseases2018

Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy.

Leslie Amass et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.